%PDF-1.3 % 1 0 obj << /OPM 1 /Type/ExtGState >> endobj 2 0 obj << /FL 1 /SM 0.01 /Type/ExtGState >> endobj 3 0 obj << /OP true /Type/ExtGState >> endobj 4 0 obj << /OP false /Type/ExtGState >> endobj 5 0 obj << /Length 7838 >> stream /GS0 gs q 0 0.157 501 700 re W n 1 g 0 700.157 0 0 re f Q /GS1 gs /GS2 gs q 0 J 0 j 10 M []0 d 0.3 w 0 0 0 1 K 14.173 668.976 m 487.559 668.976 l S Q /GS3 gs /GS2 gs q BT /F0 1 Tf 9 0 0 9 14.1732 672.0087 Tm 0 Tr 0 0 0 1 k 0 Tc 0.025 Tw (ARCH SOC ESP OFTALMOL 2008; 83: 437-440)Tj ET 0 0 0 0 k 14.173 522.811 473.386 126.322 re f Q /GS3 gs /GS2 gs q BT /F1 1 Tf 17 0 0 17 16.7404 637.5247 Tm 0 Tr 0 0 0 1 k 0 Tc 0.025 Tw [(DISMINUCI\356N DE A)55(GUDEZA VISU)60(AL, PRIMER S\352NT)17(OMA)]TJ 7.4442 -1.05882 TD (DE UN TUMOR MEDULAR)Tj ET Q /GS3 gs /GS2 gs q BT /F1 1 Tf 15 0 0 15 30.3041 587.5247 Tm 0 Tr 0 0 0 1 k 0 Tc 0.025 Tw [(VISU)60(AL A)55(CUITY LOSS, THE INITIAL SYMPT)17(ON OF A SPIN)20(AL)]TJ 10.2617 -1.06667 TD (CORD NEOPLASM)Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 11 0 0 11 38.7962 543.5247 Tm 0 Tr 0 0 0 1 k 0 Tc 0.025 Tw [(MILL\347N-R)40(ODR\352GUEZ A)39(C)]TJ ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 8.25 0 0 8.25 166.1808 547.1548 Tm 0 Tr 0 0 0 1 k 0 Tc (1)Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 11 0 0 11 170.3058 543.5247 Tm 0 Tr 0 0 0 1 k -0.0001 Tc (,)Tj 0.52484 0 Td 0 Tc 0.025 Tw [(L\347ZAR)40(O-GONZ\347LEZ V)]TJ ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 8.25 0 0 8.25 293.5102 547.1548 Tm 0 Tr 0 0 0 1 k 0 Tc (2)Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 11 0 0 11 297.6352 543.5247 Tm 0 Tr 0 0 0 1 k -0.0001 Tc (,)Tj 0.52481 0 Td 0 Tc 0.025 Tw [(DIOS-CASTR)40(O E)]TJ ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 8.25 0 0 8.25 385.4252 547.1548 Tm 0 Tr 0 0 0 1 k 0 Tc (2)Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 11 0 0 11 389.5502 543.5247 Tm 0 Tr 0 0 0 1 k -0.0001 Tc (,)Tj 0.52489 0 Td 0 Tc 0.025 Tw (R. REGAL A)Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 8.25 0 0 8.25 456.0611 547.1548 Tm 0 Tr 0 0 0 1 k 0 Tc (1)Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 11 0 0 11 460.1861 543.5247 Tm 0 Tr 0 0 0 1 k 0 Tc (,)Tj -26.96844 -1.09091 TD 0 Tw [(CORES)-275(FJ)]TJ ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 8.25 0 0 8.25 212.4005 535.1548 Tm 0 Tr 0 0 0 1 k 0 Tc (1)Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 11 0 0 11 216.5255 531.5247 Tm 0 Tr 0 0 0 1 k -0.0001 Tc (,)Tj 0.5248 0 Td 0 Tc 0.025 Tw (FERN\347NDEZ-VILA PC)Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 8.25 0 0 8.25 334.0741 535.1548 Tm 0 Tr 0 0 0 1 k 0 Tc (2)Tj ET 0 0 0 0 k 14.173 31.181 473.386 120.141 re f 0 J 0 j 10 M []0 d 0.5 w 0 0 0 1 K 14.173 133.086 m 133.228 133.086 l S Q /GS3 gs /GS2 gs q BT /F2 1 Tf 8 0 0 8 14.1732 122.915 Tm 0 Tr 0 0 0 1 k 0 Tc 0 Tw (Recibido:)Tj 4.13819 0.00001 TD 0.025 Tw (6/11/06. Aceptado: 21/5/08.)Tj -4.1382 -1.125 TD (Hospital Provincial. Complexo Hospitalario de Pontevedra. Pontevedra. Espa\226a.)Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 6 0 0 6 14.1732 107.555 Tm 0 Tr 0 0 0 1 k 0 Tc (1)Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 8 0 0 8 21.1732 104.915 Tm 0 Tr 0 0 0 1 k 0 Tc 0.025 Tw (Licenciado en Medicina. )Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 6 0 0 6 14.1732 98.555 Tm 0 Tr 0 0 0 1 k 0 Tc (2)Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 8 0 0 8 21.1732 95.915 Tm 0 Tr 0 0 0 1 k 0 Tc 0.025 Tw (Doctor en Medicina. )Tj -0.875 -2.25 TD 0 Tw (Correspondencia:)Tj 0 -1.125 TD 0.025 Tw (Alejandro Clemente Mill\207n Rodr\222guez)Tj -0.0001 Tc (Av.)' 1.7467 0 Td 0 Tc (Guti\216rrez Mellado, 4, 6.\274 B)Tj -1.7467 -1.125 TD (36001 Pontevedra)Tj T* 0 Tw (Espa\226a)Tj T* 0.025 Tw (E-mail: janoft@yahoo.es)Tj ET 0 0 0 0 k 14.173 197.8 226.772 304.011 re f Q /GS3 gs /GS2 gs q BT /F1 1 Tf 13 0 0 13 95.0622 492.9333 Tm 0 Tr 0 0 0 1 k 0 Tc 0 Tw (RESUMEN)Tj ET Q /GS3 gs /GS2 gs q BT /F1 1 Tf 11 0 0 11 14.1732 468.6334 Tm 0 Tr 0 0 0 1 k 0 Tc 0.072 Tw (Caso cl\222nico:)Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 11 0 0 11 78.6947 468.6334 Tm 0 Tr 0 0 0 1 k 0 Tc 0.072 Tw (Se presenta el caso de una mujer de)Tj -5.86559 -1.10455 TD 0.14 Tw (46 a\226os con disminuci\227n de agudeza visual en el)Tj T* 0.056 Tw [(ojo derecho y papiledema, con dilataci\227n v)15(entricu-)]TJ T* 0.243 Tw (lar en la Resonancia Magn\216tica Nuclear (RMN))Tj T* 0.01 Tw (cerebral. En la punci\227n lumbar se detect\227 hiperpro-)Tj 0 -1.10454 TD 0.079 Tw [(teinorraquia. La RMN medular re)25(v)15(el\227 la presencia)]TJ 0 -1.10455 TD 0.047 Tw (de una neoplasia de la m\216dula espinal. La paciente)Tj T* 0.103 Tw [(recuper\227 la agudeza visual tras la e)15(xtirpaci\227n qui-)]TJ T* 0.025 Tw [(r\234r)18(gica del tumor)39(, que result\227 ser un neurilemoma.)]TJ ET Q /GS3 gs /GS2 gs q BT /F1 1 Tf 11 0 0 11 14.1732 359.2834 Tm 0 Tr 0 0 0 1 k 0 Tc 0 Tw (Discusi\227n:)Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 11 0 0 11 66.6548 359.2834 Tm 0 Tr 0 0 0 1 k 0 Tc 0.077 Tw (Se comenta la presentaci\227n ocular y la)Tj -4.77105 -1.10454 TD (f)Tj 0.31299 0 TD 0.107 Tw (isiopatolog\222a de la hipertensi\227n intracraneal en el)Tj -0.31299 -1.10455 TD 0.044 Tw (tumor espinal. Asimismo se destaca la importancia)Tj 0 -1.10454 TD 0.025 Tw (del diagn\227stico etiol\227gico del papiledema. )Tj ET Q /GS3 gs /GS2 gs q BT /F1 1 Tf 11 0 0 11 14.1732 298.5335 Tm 0 Tr 0 0 0 1 k 0 Tc (P)Tj 0.60107 0 TD 0.036 Tw (alabras cla)Tj 4.64974 0 TD (v)Tj 0.49024 0 TD 0 Tw (e:)Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 11 0 0 11 89.0184 298.5335 Tm 0 Tr 0 0 0 1 k 0 Tc (P)Tj 0.54102 0 TD 0.036 Tw (apiledema, neoplasias de m\216dula)Tj -7.34513 -1.10455 TD 0.005 Tc 0.37 Tw (espinal, neurilemoma, hipertensi\227n intracraneal,)Tj 0 -1.10454 TD 0 Tc 0 Tw (hidrocef)Tj 3.32129 0.00001 TD (alia.)Tj ET Q /GS3 gs /GS2 gs q BT /F1 1 Tf 9.6 0 0 12 372.053 671.8343 Tm 0 Tr 0 0 0 1 k 0 Tc 0.025 Tw [(COMUNICA)55(CI\356N COR)40(T)89(A)]TJ ET 0 0 0 0 k 260.787 197.8 226.772 304.011 re f Q /GS3 gs /GS2 gs q BT /F1 1 Tf 13 0 0 13 339.1405 492.9333 Tm 0 Tr 0 0 0 1 k 0 Tc 0 Tw [(ABSTRA)55(CT)]TJ ET Q /GS3 gs /GS2 gs q BT /F1 1 Tf 11 0 0 11 260.7874 468.6334 Tm 0 Tr 0 0 0 1 k 0 Tc -0.013 Tw [(Case r)18(eport:)]TJ ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 11 0 0 11 321.9933 468.6334 Tm 0 Tr 0 0 0 1 k -0.0001 Tc (A)Tj 0.95895 0 Td 0 Tc -0.013 Tw [(46-year)20(-old w)9(oman, who presented)]TJ -6.52312 -1.10455 TD 0.225 Tw [(with right visual acuity loss, w)10(as found to ha)19(v)15(e)]TJ T* 0.056 Tw [(papilledema, and subsequently sho)25(wn to ha)20(v)14(e v)15(en-)]TJ T* -0.016 Tw (tricular dilatation in a cerebral Magnetic Resonance)Tj T* 0.043 Tw [(Imaging (MRI) assessment. Ele)25(v)25(ated protein le)25(v)14(els)]TJ 0 -1.10454 TD 0.089 Tw (were found in the cerebrospinal fluid. Spinal MRI)Tj 0 -1.10455 TD 0.182 Tw [(re)25(v)14(ealed the presence of a spinal cord neoplasm.)]TJ T* 0.103 Tw [(After sur)18(gical remo)14(v)25(al of the tumor)40(, which turned)]TJ T* 0.303 Tw [(out to be a neurilemmoma, the patient\325)55(s visual)]TJ T* 0.025 Tw [(acuity w)10(as restored.)]TJ ET Q /GS3 gs /GS2 gs q BT /F1 1 Tf 11 0 0 11 260.7874 347.1334 Tm 0 Tr 0 0 0 1 k 0 Tc 0 Tw (Discussion:)Tj ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 11 0 0 11 318.2498 347.1334 Tm 0 Tr 0 0 0 1 k 0 Tc 0.141 Tw (The ocular presentation and the rela)Tj 15.05899 0 TD (-)Tj -20.28284 -1.10455 TD 0.031 Tw [(tionship between intracranial h)5(ypertension and spi-)]TJ 0 -1.10454 TD 0.036 Tw (nal tumors are discussed. Lik)Tj 11.82333 0 TD (e)Tj 0.41895 0 TD (wise, the importance)Tj -12.24228 -1.10455 TD 0.033 Tw (of considering the v)Tj 8.04403 0 TD (arious causes of papilledema is)Tj -8.04403 -1.10453 TD 0 Tw (emphasized )Tj ET Q /GS3 gs /GS2 gs q BT /F0 1 Tf 11 0 0 11 315.3376 298.5335 Tm 0 Tr 0 0 0 1 k 0 Tc 0 Tw (\(Ar)Tj 1.29566 0.00001 TD (c)Tj 0.42895 0 TD -0.0001 Tc (h)Tj 0.73902 0 Td 0 Tc -0.011 Tw (Soc Esp Oftalmol 2008; 83: 437-)Tj -7.42273 -1.10455 TD 0 Tw (440\).)Tj ET Q /GS3 gs /GS2 gs q BT /F1 1 Tf 11 0 0 11 260.7874 262.0835 Tm 0 Tr 0 0 0 1 k 0 Tc 0.151 Tw [(K)25(ey w)10(ords:)]TJ ET Q /GS3 gs /GS2 gs q BT /F2 1 Tf 11 0 0 11 320.5403 262.0835 Tm 0 Tr 0 0 0 1 k 0 Tc 0.151 Tw [(P)15(apilledema, Spinal cord neoplasms,)]TJ -5.43208 -1.10455 TD 0.295 Tw [(Intracranial h)5(ypertension, neurilemmoma, h)5(ydro)-1(-)]TJ 0 -1.10454 TD 0 Tw (cephalus.)Tj ET Q endstream endobj 6 0 obj << /BitsPerComponent 8 /ColorSpace/DeviceCMYK /Filter/DCTDecode /Subtype/Image /Height 458 /Type/XObject /Length 13679 /Width 472 >> stream JFIF Adobe e C 4"@.0&4KBONJBIHS^xeSXqZHIhiq{Qdx C=""=VIV " " } !1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w !1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ? u| Q^g֭ _j<ԓ h&Զ1LxcQ) Ciӛ)3E,LFQN&h&JC[4cJM1-5\ 744fILg4IA&@RQJ;44Q(qɦCERQpL~isQKZZ(;sE!дiisI4f4RQR3M4IE4f(L *m&iԴis]֜~*e9(MYE-%.TfEF)+23ARIKHJ)V8Ss@4f+HisL9y\XZrSњJp{,*9Vp4P-sv\=FhQV5* KFi)E7%Gzv*2ئnէVnm}zO4"\NFd x :ԓ *ݚ-r| x}k xE%C&{TLii j~ꍽR!I9J(4,cu0њ)(K3bM&-R$3Fh"(\79)ph(q Xe)J))iQ@;ZLҊZ))hbvsLE!4IٕqzR4iT⒊ &kM[HE'.A-% XLJ3A)i(E&h'(PhJ*е$ot)RQEotmh[Vȡڥ)hh0nhn\њJ*p*fiA4SCњfisKEV.,xSR!l4M4--%-%妭HEf<э)EJSRҔrLL/ ZJ^ՍɸҊ4MZr$ZMD)i-$ ;5\) Q _'uVî??Ơ&?@zi(4Tpƣ<ԍME!4IG*[HTlsE!q aM0tBFV!j(CVVLE&hDrPM&iM&h]AqM&CEPh0c4=)y2QJ(1jOaMI@ C@N4R ZAp.iQIE/ZhrAE!V{SA})TRij0"њZJ(!EfERqiAҊ)i)kjlMNvCQDb=FMH4QIK͑py4P4҃L.iii)E\J 5"jTJ)i-;$ZmHR3IEk\P֦^)6ii)j% lR@IKE&Kh-p4i)҃MHlzzM=M8R \"iӷS' _'u$ x :UL ՉIHii(XӍFRQE!DM91ؘ4N4Ƥ4M4SL4QIEMl 41E-R)()*DRSiFM)U7i:dTeir %Lah<4IEKBq4KFi(h4fRQRHfisK֚x,i6Hxe(4HM:Fh-&M-2 u4ReEruTRI\li4EKCEQEP!ԠE((q4*ԉ֢J;RZAEj5DRvZ))sS)!j4LҊZ@isYp4LZuf ^N)E%*QNZm)MjAG3Ai杶GROO[\W< x&iM% =BRRVL56aRT1L=)M!4cSIETi4RQHfSI)*l+&4(!)sIJ(4Jw @lRHM-!w1&sM4h&!7!&M0ҭ-%V~)y/JZ*\Iq#"ȦT"\zQ 4ӳM5qi4fU{ޡ\sJ)ii)iǃNZb QK@DON%%:CzxZBZ1KEFhVQEZJ#viʴ)hI"'AL44RRӹHJ N)hhuQKKS*-j(̇tIN SɤG0:)FhW$54iVS%")۪$g _'f???Σ5cU$DT URRVr`1B#TmE%-%C6N4Hi)i*,cS 50J)i(J!ӶьRQALSyJ9S'8\f(qh3OeRQR@ҊNbN"4Ӆ# J(䱹4REŢ3ERSaA.iRw$ C)EHLaژih4TQHiI*J)N=M9iOZpEkhژ(h;hJZ|Zf3ERQ>bLfih&r44R ZRe6KLMɥ!)h i)RRSO^4h)h4KQKIJ)x45-=i٦-"['Ju2ERO+bk??Ϋ6j??ΫژE=FZZmCj3E%-!4M+N"R)) n)idE%-%fci)M4QE+-EQjCh8JQIEK% vsE-!MKDaiƣj)i)jb))E-%RdHii(fh-5QSA %f@iX3KJLYܛII)ݩ)3EirA))UmF8S0zu)Z[/4/JchYI4QJ3E4fJ(\~h34QIJ*d4)֞ 8RRҸHSf)EޝBZZJZ S0p4fP;SN 9yKN<p pRS1}iisMSKI6%Jvii٨ _'u, x :sgJ؞㙤 x :§8O ⒊(v&ZaSR1-IIKIP < m:i\a4Fh4QlFjoZ 4) lA4ihؤfZ(HE%-Rg'`3N&JBl549-%̮&isII\њJ3@\q4f LIHNn;4fLԄf4j^⛚@ԄA4Ѻuji⮛qz <rp4545SA#85ijZm(=jWBQ9E5{QGj+Jt(PAf5QE8tњUU66ǭ.iKKIE+diA PiE8SE.iH 9MF)NR 8Sǭ=iNrҊm(9M0p4NqJЙ)S9 uK???өlMsOV.O x :QEi֘Ԕ) CcRu!! 8M4 -%I,aO4M4RR!E8hC)K))j)Pi3A4QHi3A"i4PK g4QEZ CKA4McB"PM%!4KTll HM&jB54dٓb4QSo#5[uHԕ-C4z7TD@j%QE0